Drug Type Synthetic peptide |
Synonyms Thymic humoral factor, Thymic humoral factor gamma-2, FCE 25388 + [2] |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC43H67N9O13 |
InChIKeyNYJVPTKMDYSZDU-MRNVWEPHSA-N |
CAS Registry107489-37-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
HIV Infections | Phase 2 | United States | 31 Aug 2001 | |
Virus Diseases | Phase 2 | United States | - | - |
Virus Diseases | Phase 2 | Germany | - | - |
Virus Diseases | Phase 2 | Switzerland | - | - |
Virus Diseases | Phase 2 | United Kingdom | - | - |
Neoplasms | Preclinical | Israel | - | - |